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ENGLISH ABSTRACT 
 
    Schistosomiasis is an important human helminth infection in terms 
of morbidity and mortality.  Approximately 200 million people in 74 
countries are infected with schistosomes. Risk of schistosomiasis in 
Sudan is widespread, particularly in the irrigation schemes. This study 
was carried out to measure total specific IgG and IgG subclasses 
against Shistosoma mansoni soluble worm antigen (SWA) in infected 
school children. The study area was Elkeryab village situated in the 
Eastren Nile Locality in Khartoum State. The study population was 
Keryab’s school children. Blood samples were collected from 40 
infected children and 20 non-infected to serve as control. The children 
were divided into three groups: A, B and C according to age, very 
young ones (5-7 years), middle group (8-11 years) and teenagers (12-
16 years). The duration of the study was one month during summer.       
Enzyme-linked immunosorbent assay (ELISA) was used to detect the 
levels of the IgG and IgG1, IgG2, IgG3 and IgG4   against S. mansoni 
(SWA). There were differences among the three age groups in the 
intensity of infection. The intensity of infection increased significantly 
with age.There was a remarkable difference in the total specific 
immunnoglobulin levels and its subclasses against SWA in the 
different age groups of infected children that was not reflected in the 
control groups. The responsesof IgG and IgG subclasses against 
SWA varied considerably within each age group of infected children, 
where there were no differences of these antibodies within each age 
group of non infected children. The research confirmed that the 
intensity of infection and age are primary factors in inducing IgG 
isotype responses against SWA between the infected children .The 
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highest levels of immunoglobulins were obtained in the older chidren 
(12-16years), where the lowest levels of immunoglobulins were 
obtained in the younger chidren (5-7years). The results also confirmed 
that there were differnces of IgG isotype responses against 
SWAwithin the age groups of infected children. 
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CHAPTER ONE 
INTRODUCTION AND LITERATURE REVIEW 
1.1 Itroduction: 
Schistosomiasis (also known as Bilharzia) is a major 
communicable disease in the developing world. It is caused by 
trematode fluke worms of the genous Schistosoma. Each species of 
schistosoma requiring a different freshwater snail intermediate host to 
complete its life cycle (Steinmann et al., 2006). Five schistosome 
species infect humans; Schistosoma mansoni, S. japonicum, 
S.mekongi, S.intercalatum and S.haematobium. The first four species 
have well described associations with chronic hepatic and intestinal 
fibrosis and their consequences. S.haematobium infections cause 
fibrosis, structuring and clacification of the urinary tract. 
S.mansoni and S.haematobium are predominantly human parasites 
(Van der werf et al., 2003). 
It is estimated that 780 million people are at risk of contracting 
Bilharzia, with more than 200 million actual cases (Steinmann et al., 
2006). Approximately 200 million people in 74 countries are infected 
with schistosomes; 120 million are symptomatic, and 20 million suffer 
severe illness (King et al., 2006). The number continues to rise, 
despite the implementation of control programmes, due to the 
introduction of wide-scale irrigation schemes which help the snail host 
to disperse (Steinmann et al., 2006). Schistosomiasis is concentrated 
in sub-Saharan Africa with the highest prevalence and infection 
intensities usually found in schools children and young adults. 
Mortality rate in this region due to S. mansoni and S. haematobium is 
estimated at 280,000 deaths a year (Van der werf et al., 2003).  
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 Both S.mansoni and S. haematobium are present in Sudan and 
the risk of contracting schistosomiasis in considerable, especially in 
major irrigation systems (Deganello et al., 2007). 
The objectives of this study were: 
1. Determination of total specific immunoglobulins IgG and its 
subclasses IgG1, IgG2, IgG3 and IgG4 against Shistosoma 
mansoni Soluble Worm Antigen (SWA) in school children 
of different ages. 
2. To examine the effect of host age on total specific 
immunoglobulins IgG and its subclasses. 
3. To examine the effect of intensity of infection on total 
specific immunoglobulins IgG and its subclasses. 
4. To investigate which subclass predominates in S.mansoni 
infection.  
1.2 Literature review: 
1.2.1 History:   
Historically schistosomiasis has been endemic for many years 
in the NileValley. Large numbers of calcified eggs of the parasite 
were found by Ruffer (1910 a and b) in two Egyptian mummies 
(1000–1250 B.C.).  S. haematobium living worms were described by 
Bilharz (1853 a and b) for the first time, when he found the worms in 
the viens draining to the ureters. Later he established their relationship 
to haematuria seen in Egyptians who were passing, terminal spined 
eggs of the parasite in their urine. The existence of two different 
species of the parasite was established by the discovery of lateral 
spined eggs in human feces in the West Indies and Uganda by Manson 
(1902) and Castillani (1903), respectively. 
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It was demonstrated by Lieper (1915 a and b) that the worms 
with different eggs were distinct species, with different allocations in 
the definitive host, and that they utilized snail intermediate hosts 
belonging to two different genera, Bulinus and Planorbis (now 
Biomphalaria) for S. haematobium and S. mansoni respectively. 
1.2.2 Biology: 
Several worms of the family schistosomatidae are capable of 
infecting humans. The worms of only five species are known to 
proceed to maturation and oviposition in humans. Human infection is 
initiated by the parasite cercaria, which are shed in fresh water from 
infected snail intermediate hosts. Cercaria are capable of penetrating 
human skin and transform in the first parasitic stage, schistosomulum 
which differ in many ways from the free-living cercariae. Upon 
penetration of human or other mammalian hosts, the organisms face 
several changes in their environment, these changes pose different 
biochemical, nutritional and immunological challenges. The 
schistosomulum faces these obstacles with remarkable success. The 
most remarkable adaptation occurs in the surface membrane of these 
organisms. Schistosomulum is bound by trilaminate membrane similar 
to other biological membranes. The schistosomulum undergoes both 
immunologic and a maturational change during it is migratory 
pathway. Mature adult male and female worms then move to the 
circulatory system. Sexually mature worms mate egg deposition by 
female occurs intravascularly (Mahmoud, 1992). Eggs are enclosed in 
a characteristically shaped shell and through the secretion of histolytic 
enzymes, some of these eggs move from the intravascular bed through 
the host tissues to reach the lumen of the gut or urinary tract 
(Mahmoud, 1992).  
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1.2.3 Life cycle of the parasite:  
All schistosoma infections follow direct contact with freshwater 
harboring free-swimming larval forms of the parasite that is the 
cercariae. (Figure1). Cercariae penetrates the skin of humans or other 
mammalian hosts. The cercariae shed its tail and enter capillaries and 
lymphatic vessels en route to the lungs. After several days, the young 
worm, or schistosomulum, migrate to the portal venous system, where 
they mature and unite. These pairs then migrate to their ultimate 
vascular bed, i.e., mesenteric veins (S. mansoni), or the viens draining 
to the ureters (S. haematobium). Egg production commences four to 
six weeks after infection and continues for the life of the worm, which 
can be up to 15 years in the definitive host. Eggs are deposited in the 
vein lumen. The female produces hundred (S. mansoni) to thousands 
(S. jabonicum) of eggs per day. Eggs pass into the host tissue, and 
then many of it pass through the intestinal or bladder mucosa and are 
shed in the urine (S. haematobium) or feces (S. mansoni). The life 
cycle is completed when the eggs passed in the feces (in the case of   
S. mansoni) hatch, releasing miracidia that infect specific freshwater 
snails (infect Biomphalaria species). After two generations of primary 
and the daughter sporocysts within the snail, a sexually produced 
cercaria are released (Ross et al., 2002; Gryseels et al., 2006). 
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Fig. (1):  The life cycle of Schistosoma mansoni 
                                 (WWW.dpc.cdc.gov) 
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1.2.4 Transmission:  
Schistosomiasis transmission arises from agricultural practices 
and water resource manipulation, particularly if there is poor 
sanitation and substantial water contact. Environmental changes 
linked to water resource development, population growth and 
migration, have facilitated the recent spread of schistosomiasis to 
areas where it was not endemic (Ross et al., 2001; 2002; Gryseels et 
al., 2006; Li et al., 2007). Population displacement has introduced S. 
haematobium into Somalia and Djibouti (Gryseels et al., 2006).  The 
Diama Dam on the Senegal River and The Aswan Dam on the Nile 
River introduced S. mansoni to Mauritania, Senegal and Upper Egypt 
respectively (Gryseels et al., 2006).  
1.2.5 Geographical distribution: 
1.2.5.1 Global distribution: 
Among human parasitic diseases, schistosomiasis rank second 
behind malaria in terms of socio-economic and public health 
importance in tropical and sub-tropical areas. The disease is endemic 
in 76 developing countries in Latin America, Africa and Asia (WHO, 
1993). S. jabonicum is found in Eastern Asia and the Phlippines, S. 
haematobium is found in Africa and parts of the Middle East (King, 
1991). S. mansoni is a parasite that is found in different parts of the 
world. Parasitism by S. mansoni affects approximately 120 million 
individuals living in Brazil, Suriname, Venezuela, several Caribbean 
Islands, Egypt, most of the countries in the West, equatorial, central 
and south regions of Africa and in the Arabian Peninsula. These 
geographical patterns are determined by the ecologic range of each 
schistosome specific snail vector in which the parasite undergoes 
much of its complex development. S. mansoni is a serious public 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
health problem in these countries not only because of the large 
number of infected individuals, but also because of its severe forms, 
e.g. the hepatosplenic form, which in endemic areas accounts for high 
rates of hospitalization, disability and mortality (Goncalves et al., 
1995). Schistosomiasis infecting more than 200 million people in rural 
agricultural and peri-urban areas, places more than 600 millon at risk. 
Of the infected patients, 20 million suffer severe consequences from 
the disease and 120 million are symptomatic. There are approximately 
20,000 death related to Schistosomiasis yearly (Oliveira et al., 2004). 
1.2.5.2 Incidence and prevalence in Sudan: 
         Schistosomiasis is endemic in certain parts of Sudan, in 
particular areas where irrigation canals provide a habitat for its snail 
vector. About 180,000 cases were reported in 2000 (Kheir et al., 
2000). 
In the northern region in Lake Naser the prevalence of 
schistosomiasis was 30% (Omer, 1978). The endemicity since then 
has increased in many parts of Sudan as a result of the expansion of 
water resources development projects (WHO, 1985).When the 
agricultural scheme in the Gazira Province opened, Schistosomiasis 
started to appear. By the late seventies, the prevalence was over 50%. 
The Blue Nile Health Project (BNHP) was implemented to control the 
water associated diseases in the irrigated schemes along the Blue Nile 
River. These succeed in reducing the prevalence of S. mansoni to less 
than 10 % (BNHP, 1990). However the (BNHP), has stopped its 
activities in 1990 and there is evidence that the prevalence rate started 
to increase again since then (Hilali et al, 1995., Babiker et al, 1996 a 
and b). 
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Studies in irrigation schemes in the Gazira have shown 
prevalence of 30% to 50% in endemic villages (Hilali et al., 1995; 
Kheir et al., 1999). The Epidemiological surveys in the Gazira-
Managil schemes showed that the prevalence of S. mansoni was 60% 
and S. haematobium was 50% (Hilali et al., 1995; Babiker et al., 1996 
a and b). 
Kheir et al. (1999) found that the mortality due to S. mansoni to 
be 51/100,000/year in the general population and 1/1000/year in adult 
males in the Gazira area and showed the impact of schistosomiasis on 
public health in this economically important region of Sudan. 
The overall prevalence of S. mansoni and S. haematobium 
infections in the former White Nile Province where agricultural 
schemes such as Asalya and Kenana was found to be 10.1, 21.4 % 
respectively (Ahmed, 1994).    
A few studies were conducted in Khartoum State. These studies 
showed that there is transmission of S. haematobium in the capital 
Khartoum (Malek, 1960, 1962; Amin and Omer, 1972). Hilali et al. 
(1995) in their studies pointed out that the over all prevalence of 
schistosomiasis was 14.2%. 
In eastern region, prevalence of schistosomiasis was 
demonstrated by Omer (1978) and Abdel Galil (1980) in New Halfa 
and Khashm Elgerba respectively. 
In Western Sudan region a prevalence of schistosomiasis was 
found to be 14% in Kordofan (El toum, 1976).  
Since the 1970s, few observations on the prevalence of 
schistosomiasis in the southern Sudan have been made.  Endemicity of 
S. mansoni in the southern part of the country was reported by Omer 
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(1978). Magambo et al. (1998) reported S. mansoni prevalence of 
2.2% among children in two primary schools in the East Equatoria 
region. A report conducted in Juba showed that 66% of refugees were 
harboring intestinal helminthes, and in 26% of cases it was S. 
mansoni. 
Deganello et al. (2007) found that there was a high prevalence 
of S. mansoni infection in some areas in West Equatoria region and 
showed that both S. mansoni and S. haematobium are highly endemic 
in the Upper Nile region. These collected data facilitated 
Schistosomiasis control intervention in the area via mass distribution 
of praziquantel to all schoolchildren since 2003 (WHO, 2002).  
1.2.6 Pathogenesis: 
Pathological consequences that occur in infected individuals 
depend on the host as well as the parasite. Individuals infected with 
Schistosomiasis encounter cercariae, maturing Schistosomulum, adult 
worms and parasite ova (Chen and Mott, 1988; King, 1991). Most 
chronic morbidity in schistosomiasis is not due to the adult worms but 
is related to the T-cell-dependant immune response of the host, which 
is directed against schistosome eggs trapped in tissues, mainly in the 
liver and intestines in the case of intestinal forms  (S. mansoni) and in 
the bladder in the case of   (S. haematobium). The trapped eggs secrete 
molecules leading to a marked CD4+ T-cell programmed 
granulomatous inflammation involving  eosinophils, monocytes and 
lymphocytes, akin to a form of delayed-type hypersensitivity. 
Granulomas are also characterized by collagen deposition, and in the 
intestinal schistosome, severe hepatic periportal fibrosis occurs 
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(Pearce and  MacDonald, 2002; Stadecker et al., 2004 ; Wynn et al., 
2004 ; Pearce, 2005; Taylor et al., 2006; Wilson et al., 2007).   
The disease can be divided into three stages based on its 
Parasitological, clinical and pathological characteristics: 
1.2.6.1 Invasion and migration of the parasite: 
During the initial invasion stage by the carcariae there may be a 
localized dermatitis as a cutanous inflammatory response to skin 
invasion by the carcariae. It involves antibody as well as cell mediated 
immunological response (Chen and Mott, 1988; King, 1991).  
After the transformation of infective larvae into 
schistosomulum in the skin of appropriate host and over several 
weeks, it develops into sexually mature egg-lying worms (Capron, 
1992). 
1.2.6.2 Established infection: 
This stage is characterized by extensive oviposition by female 
worms leading to bloody stools (S.mansoni) or urine (S. 
haematobium) caused by the passage of eggs through the intestinal 
and urinary bladder walls. About two thirds of the eggs never pass 
through, and a large number build up in the gut or bladder walls. In 
addition, many eggs are never expelled from the venules but are swept 
away by the blood. In the case of S. mansoni the hepatic portal system 
carries many eggs to the liver where they are trapped and elicit 
inflammatory reactions resulting from leucocyte and fibroplastic 
infiltration, so called granulomas. It is these progressively 
accumulating granulomas that give rise to the pathology of the 
disease. Eggs may also reach other parts of the body, such as the lungs 
and the heart (Kullberg, 1995).  
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The clinical symptoms of the disease that may develop include, 
fever, chills, weakness, headache, diarrhoea, liver tenderness and 
enlargement, and cough (Alves-Brito et al., 1992). 
1.2.6.3 Late infection: 
This stage develop after prolonged infection and leads to severe 
intestinal, hepatic and renal pathology caused by the reaction of the 
host to the eggs. Over time, liver granulomas lead to formation of scar 
tissue with collagen deposition and fibrosis. During this stage of the 
disease, the numbers of eggs excreted are often reduced. 
This stage of S. mansoni can be divided into two types: the 
intestinal and the hepatosplenic forms. In the intestinal form, the main 
lesion is intestinal inflammation and fibrosis with complications such 
as diarrhoea, constipation and faeces with blood and mucus. The liver 
is enlarged, but the hepatic function is normal. In the more severe 
hepatosplenic form of the disease, pathology is mainly due to 
extensive fibrosis in the portal tracts of the liver, leading to reduced 
portal blood flow and portal hypertension, sometimes causing 
gastrointestinal bleeding which can be fatal. Accumulation of fluid in 
the abdominal cavity, so called ascites, is also common in hepato-
splenic disease (Kullberg, 1995). 
1.2.7 Immunity to schistosomiasis: 
The immunological interaction between schistosomes and their 
hosts are complex processes and many host effector mechanisms were   
found to play a role (Smithers and Doenhoff, 1982).  
Schistosomes present in their hosts a multitiudes of antigens due to 
different stages. These antigens elicit a variety of immune responses, 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
which may either be protective or pathological (Butterworth, et al., 
1989; Mahmoud, 1992). 
During schistosome infection, two stages of the parasite can be 
considered to be of a primary immunogenic importance, the adult 
worms and the eggs (Pearce and Simpson, 1994). 
S. mansoni surface membrane components play a relevant role in the 
host-parasite interaction, and some are released in vivo as circulating 
antigens. n-butanol extraction favors the release of membrane antigens 
like alkaline phosphatase,   which has been shown to be specifically 
recognized by antibodies from S. mansoni infected humans and 
animals (Cesari et al., 2005).  
It is agreed that antibody-dependent mechanisms play a major 
role in the expression of acquired resistance to schistosome infection. 
The major role of antibodies in protective immunity is to induce 
cytotoxic destruction of schistosomulum as targets (Capron, 1992). 
Experimental studies investigating immunity to S.mansoni showed 
that infected animals were able to destroy the young schistosomula 
during the infection but didn’t eliminate adult worms that had 
established themselves during initial infection (Smithers and Terry, 
1969). The adult worms may evade the immune system by changing 
their outer surface antigen or by acquiring host molecules. Many 
studies showed that marked fall in the intensity and prevalence of 
infection occur in adults is attributed to the development of acquired 
immunity and resistance to re infection, reduced exposure to infected 
water and to the gradual spontaneous death of the worm (Wilkins, 
1977; Sturrock et al., 1983; Butterworth et al., 1984, 1985, 1992, 
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1994; Hagan et al., 1987; Wilkins, et al.1987; Dessein et al., 1988, 
1992).      
Experimental studies on the mechanism of acquired immunity 
showed that Antibody-Dependent Cell-mediated Cytotoxicity 
(ADCC) appears to be the main mechanism of killing parasites both in 
rat and human schistosomiasis (Capron, 1992). Immunologically 
novel forms of (ADCC) were discovered involving eosinophils, 
neutrophils, monocytes and platelets and antibodies of the IgG, IgE 
and IgA classes (Taylor, 1994). The efficacy of  (ADCC) depends 
upon the presence of appropriate antibodies and activated eosinophils 
which can be activated by a variety of  activating moieties including 
Eosinophil Activating Factor (EAF) (Veith and Butterworth, 1983; 
Thorne et al., 1985), Tumor Necrosis Factor (TNF), Granulocyte 
Macrophage Colony Stimulating Factor (G-MCSF)  (Silberstein and 
David ,1986a Silberstein et al.,1986b), Interlukin-5 (IL-5) (Lopez et 
al., 1988), platelet Activating Factor (PAF) (Walsh et al., 1989) and 
Eosinophil Cytotoxicity Enhancing Factor (E-CEF) (Lenzi et al., 
1985). 
In all animal models, and in humans, elevated IgE 
concentration, and blood tissue eosinophilia are hall marks of 
schistosomiasis (Dunne et al., 1992a and b). In vitro experiments have 
shown the capacity of IgE and IgG2 to mediate killing of 
schistosomula in the presence of monocytes, macrophages, 
eosinophils or platelets. In addition mast cells, triggered through their 
high affinity receptors for IgE (Fce RI), release of mediators that can 
increase the cytotoxicity of other effector cells (Capron and Dessaint, 
1992).  It was demonstrated by Dunne et al. (1992a) that IgE antibody 
against the S. mansoni adult worm antigens correlated positively with 
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age and negatively with re-infection. The role of IgE in several 
immune mechanisms against the parasite has been described in vitro, 
suggesting that these mechanisms might be involved in protection 
against human schistosomaisis (Capron et al., 1999). 
In addition to the IgE response, there is an unsuspected 
association of specific IgA against schistosoma enzyme Glutathione S-
Trasferase (GST) and acquisition of immunity. The IgA play a potent 
neutralizing effect on enzymatic properties (Grzych et al., 1993). 
(GST) can induce a significant protective immunity after direct 
immunization in various experimental models. IgA also impairs 
schistosoma fecundity by limiting both egg lying of mature worms 
and hatching capacity of eggs (Grzych et al., 1993).  
Early studies demonstrated that the apparent resistance to re- 
infection was related to high eosinophil counts and levels of 
antibodies that mediate eosinophils damage of schistosomula 
(Sturrock et al., 1983; Hagan et al., 1987). 
IgG antibodies and eosinophils have been shown to kill 
schistosomula of S.mansoni in vitro. IgG demonstrated a killing effect 
only in the presence of eosinophils activated in vivo or normal 
eosinophils activated in vitro by eosinophils activating factors 
(Khalife et al., 1989). 
Analysis of antibody subclasses involved in the immune 
response against the schistosome is important both for disease 
pathogenesis and in mediating   immune protection because of their 
role as blocking antibodies and protective antibodies (Capron and 
Dessiant, 1985; Butterworth et al., 1987, 1988). 
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The functional role of IgG subclasses in (ADCC) is that IgG1 
and IgG3 would mediate eosinophil killing of schistosomula, and that 
IgG2 antibodies expressed a dual function; an effector function with 
activated eosinophils and blocking function with normal eosinophils. 
IgG4 irrespective of the condition of the eosinophil blocked the killing 
mediated by IgG effector antibodies (Khalife et al., 1989). 
IgG subclasses vary in their ability to mediate immune effector 
mechanisms directed against schistosomes (Dunne et al., 1993). The 
overall immune status of infected individuals, therefore, may depend 
upon the distribution of anti-schistosome subclasses. Infected 
individuals exhibited considerable diversity in IgG subclass   
responses which characterized by affinity maturation and isotype 
switching (Dunne et al., 1993).   
There is increasing evidence that isotype switiching is 
controlled by a number of cytokines. In mice IgG1, IgA and IgE 
productions are controlled by Interlukin-4 (IL-4), IgG2 by Interferon-
gamma (IFN-? ). Secretion of IgG3 may be under the control of (IFN-
? ). In human IgE and IgG4 antibody appear to be potentiated by IL-4 
and IL-13 (Spiegelberg et al., 1991; punnonen et al., 1993).     
Studies performed in mice or rats infected with helminths 
suggest that besides the induction of IgE synthesis, IL-4, in 
association with other cytokines such as IL-3, IL-9 and IL-13, 
stimulates the production of mast cells (Comoy et al., 1998; Else and 
Finkelman, 1998; Keane-Myers et al., 1998; Urban et al., 1998). Once 
stimulated these cells release inflammatory mediators capable of 
damaging the parasite membrane, stimulating secretion of mucus and 
enhancing the intestinal contractility in order to expel the parasite. 
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 In mice, a predominantly Th1 reaction in the early stages of 
Schitosoma infection shifts to an egg-induced Th2, and imbalances 
between these responses lead to severe lesions (Pearce and 
MacDonald, 2002; Stadecker et al., 2004 ; Wynn et al., 2004 ; Pearce, 
2005; Taylor et al., 2006; Wilson et al., 2007). A notable 
accomplishment in the past few years was the identification of 
interleukin-13 (IL-13) and its receptor complex as central regulators 
of disease progression in schistosomiasis (Mentink-kane and Wynn, 
2004; Wynn et al., 2004; Reiman et al., 2006). Data from studies in 
mice have established that critical control of inflammatory cytokines 
such as interleukin-17 (IL-17) is necessary to prevent disease 
symptoms from becoming severe (Pearce and MacDonald, 2002; 
Wilson et al., 2006). Similar regulatory control could be at the basis of 
fibrotic pathology in humans (Abath et al., 2006), although this has 
not yet been established. 
Perhaps the most important clue of all understanding protective 
immunity to shistosomiasis is the naturally acquired immunity 
displayed by some individuals in Brazil in the absence of prior drug 
treatment (Viana et al., 1994, 1995; Correa-Oliveira et al., 2000). This 
small but well-defined cohort is referred to as putative Resistant (PR) 
individuals (Tran et al., 2006). These individuals are resistant to 
infection despite years of exposure to S. mansoni. PR individuals 
mount vigorous but very different (compared to those heavily infected 
patients) immune responses to crude S. mansoni extracts from 
schistosomula and  adult worms (Viana et al., 1994, 1995; Caldas et 
al., 2000). In response to stimulation with these antigens, blood cells 
from PR individuals secrete both Th1 and Th2-type cytokine responses 
(Bahia-Oliveira et al., 1996; Caldas, et al., 2000), while the late 
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infected individuals make a Th2-type response (Robert et al., 1993).  It 
is the Th1 response (particularly IFN-? ) to shistosomulum antigens that 
is thought to be the key to resistance to shistosomiasis in these 
subjects (Correa-Oliveira et al., 2000). Recent studies described the 
use of PR individuals to select two new vaccine antigens that are 
expressed in the tegument membrane of S. mansoni namely SmTSP-2 
(Tran et al., 2006) and Sm29 (Cardoso et al., 2006). Both proteins 
were recognized by the sera from PR individuals as opposed to sera 
from late infected patients, supporting the potential of the PR immune 
response to guide discovery of tegument membrane proteins as 
recombinant vaccines (Loukas et al., 2007).  
1.2.8 Diagnosis:  
In spite of the prolific generation of new knowledge in the area 
of schistosomiasis, there are some unsolved practical issues associated 
with the diagnosis and control of this parasitic disease. This is 
particularly true, in relation with the laboratory diagnosis of this 
relevant trematode infection (Alarcon de Noya et al., 1999). 
The stool examination by kato-katz technique (Katz et al., 
1972) which detects the eggs/g of feces has conventionally been 
considered the best tool for diagnosis of intestinal schistosomiasis 
infection. This is true when patients eliminate more than 100 eggs/g of 
feces. In some countries in which approximately 80% of the 
Schistosomiasis infected individuals harbor light infections (eliminate 
less than 100 eggs/g of feces), the detection of infected individuals is 
difficult (Alarcon de Noya et al., 1999).  When the stool examination 
by kato-katz technique is done, the sensitivity of the stool examination 
decreases to approximately 60% (Alarcon de Noya et al., 1992a; El-
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Morshedy et al., 1996). The sensitivity of the stool examination 
diminishes when patient presented with prevailing late infection and 
excrete less than 100 eggs/g of feces (Alarcon de Noya et al. 1992a). 
Circummoval Precipitate Test (COPT) (Oliver-Gonzalez, 1954) 
based on the low sensitivity obtained by the kato-katz technique, 
revealed the best performance, reaching a range of sensitivity of 92-
100% and specificity of 96-100% (Spencer et al., 1991; Alarcon de 
Noya et al., 1992a).  
Immunodiagnostic methods based on the detection of antibodies 
continue to be the most effective and practical methods of diagnosis 
(Tsang and Wilkins, 1997). 
 Enzyme-linked Immunosorbent Assay (ELISA) with crude 
extracts of adult worm or egg antigens based on detection of 
antibodies have good sensitivity (Colmenares et al., 1993). A great 
variety of antigens have been employed (Pardo et al., 2004).  
Pardo et al. (2004) used complete S. bovies which is a species whose 
final host are bovine, ovine and small wild ruminants (Barber et al., 
2000; Hamburger et al., 2001), they used Adult Worm antigens 
(AWA) for the detection of antibodies by ELISA with the specificity 
achieved 97%, and they conducted that the S. bovies AWA is a useful 
test for the diagnosis of S. mansoni and S. haematobium, comparable 
with other techniques used for the diagnosis of schistosomiasis. 
A major break-though was recently achieved with a method 
based on the amplification of a highly repeated DNA sequence by 
polymerase Chain Reaction (PCR) in fecal and serum human samples. 
The high sensitivity and specificity of this test constitutes a very 
valuable alternative as a confirmatory test for diagnosis (Pontes et al., 
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2001). Nevertheless, its cost and sophisticated laboratory equipments 
and conditions, limits the use of this assay in central laboratories. 
Pontes et al. (2002) have demonstrated the ability of PCR in the 
diagnosis of infection with S. mansoni.  
1.2.8.1 Isotype immune response in the diagnosis of 
schistosomiasis     pathology: 
           Humoral immune responses directed to adult worm and egg 
antigens of schistosomes are well documented during human infection 
but very few clinical data showing a relationship between specific 
antibody responses and morbidity to schistosomiasis (Bonnard et al., 
2004). 
The pathology of schistosomiasis is induced by fibrosis due to 
the deposition of eggs in tissues. In the case of S. mansoni infection, 
hepatic fibrosis, hepatosplenomegaly and portal hypertension are the 
major causes of schistosomiasis morbidity and mortality. So the use of 
Ultrasonography is a direct marker of morbidity, even for detecting 
the lowest form of pathology (Hatz, 2001). It seems essential to 
develop complementary and effective methods to evaluate 
schistosomiasis pathology before the outcome of portal hypertension. 
         Bonnard et al. (2004) detected a possible variability of the 
specific humoral immune response in a cohort of S. mansoni infected 
patients with different pathologic stages. The patients were stratified 
into three different stages of pathology according to clinical 
examination and abdominal Ultrasonographic, stage1: no detectable 
pathology; stage2: moderate pathology; stage3: severe form of 
pathology. 
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The specific IgG1, IgG2 and IgG3 responses were similar 
between patient groups. In contrast IgG4 and IgE and IgA varied 
according to the stage of Pathology. The IgA were significantly higer 
in (stage 2 and 3) compared with (stage 1). IgA response were higher 
in (stage 3) compared with (stage 2) but no statistically difference was 
observed. IgG4 levels were observed only in (stage 3). A similar IgG4 
response was observed in (stage 1 and 2), and the increase in this 
isotype response in (stage 3) compared with (stage 2) was highly 
significant. A statistically significant difference was found for IgE 
response between (stage 1 and 3), this isotpe levels were higer with 
increasing morbidity (stage 1 to stage 2 and stage 2 to stage 3). 
The use of this immunologic marker could be helpful in identifying 
patients with earlier stages of pathology so that they could be included 
in monitoring programs (Bonnard et al., 2004). 
1.2.9 Methods of control:  
 The key to designing schistosomiasis control methods is to 
understand how the disease is transmitted, this knowledge has been 
widely available for many years by which time the very complex life 
cycles of all the major schistosoms of man had been completely 
worked out. However, the application of control measures, 
particularly population based Chemotherapy, has in many countries 
greatly reduced the incidence of serious disease manifestations, but 
vaccines are urgently needed to supplement existing control measures 
(Taylor, 1994).  
1.2.9.1 Human behavior and snail control:  
It was clear that, at least in theory, the disease could be attacked 
by removing the adult worms with drugs, by eliminating the snail 
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hosts by habitat modifications or the use of molluscicides, by 
changing human behavior by health education, and by the provision of 
safe water supplies so that excrete containing live eggs do not reach 
water containing snails and people avoid water contaminated with 
cercariae. However, such measures could evidently be applied only if 
social and political circumstances in endemic areas were conductive 
(Taylor, 1994). 
Snail control was introduced in the 1920s, when copper 
sulphate was shown to be lethal to the aquatic vector. The use of 
another chemical; niclosamide which is very expensive proved to have 
bad effect on environment (Farag, 1988).  
1.2.9.2Chemotherapy:  
In spite of the large number of S. mansoni-infected individuals 
and the existence of severe forms leading to high rates of morbidity 
and mortality, it is possible, through  early diagnosis and specific 
Chemotherapeutic treatment, to reduce the S. mansoni carriers and 
prevent progression to the more severe forms of the disease (Jordan  
and Webbe, 1993). Since the introduction of the treatment of 
schistosomasis in 1918, a number of drugs have been used for that 
purpose. It was only during the 1970, however, that 
Chemotherapeutics of proven efficacy and low toxicity including 
oxamniquine (OX) and praziquantel (PZQ), were developed, both of 
which have been widely used (Gonnert and Andrews, 1977; WHO, 
1993). Both drugs kill the adult worms (Pica-Mattocia and Cioli, 
1985; Harnett, 1988), thus preventing oviposition and the consequent 
embolization of eggs in the circulation.  
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        Massive chemotherapy with OX or PZQ (Cline et al., 1982; 
Andrews et al., 1983; Cioli et al., 1993) has been one of the most 
important measures in the control of schistosomiasis in endemic areas. 
While resistance to OX is well documented, such has not been the 
case of PZQ. Nevertheless, there have been reports of possible failure 
in the treatment of human infected with S. mansoni in some countries 
(Tavares-Neto and Prata, 1988; Katz et al., 1991; Anonymous, 1992). 
1.2.9.3 Vaccination: 
  In spite of remarkable chemotherapeutic progress and the 
existence of highly effective molecules such as the Paraziquantel 
(PZQ), there is still a spreading of schistosomiasis into new areas. 
After over 20 years of experience, it is generally agreed that 
chemotherapy, although the mainstay of current schistosomiasis 
control programs (Blas et al., 2004; Utzinger et al., 2005; Fenwick 
and Webster, 2006; King et al., 2006), have some limitations. In 
particular, mass treatment does not prevent re infection. This occurs 
rapidly in exposed populations in most areas of endemicity. This can 
make chemotherapy an expensive often impractical approach. 
Although there is not yet clear-cut evidence for the existence of PZQ –
resistant schistosome strains, decreased susceptibility to the drug has 
been observed (Doenhoff and Pica-Mattocia, 2006; Gryseels et al., 
2006), in Africa, by large-scale use of PZQ. There is increasing 
concern about parasite resistant development (Fenwick and Webster, 
2006). In a situation of ongoing high transmission and interrupted 
chemotherapy, severe hepatosplenic disease is well documented for 
schistosomiasis (Ross et al., 2002; King et al., 2005). As a result, 
vaccine strategies represent an essential component as an adjunct to 
chemotherapy for the future control of schistosomiasis. 
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Vaccination against schistosomes can be targeted towards the 
prevention of infection and/or to the reduction of parasite fecundity.  
A reduction in worm numbers is the main aim for antischistosome 
vaccine development, with the migrating schistosomulum stage likely 
to be the major vaccine target of protective immune responses 
(McManus, 2005; Wilson and Coulson, 2006). A vaccine targeted at 
parasite fecundity and eggs viability also appears entirely appropriate.  
Despite the discovery and publication of numerous potentially 
promising vaccine antigens from S.mansoni; only one, namely 
Glutathione S-Transferase 28 [Sm28-GST] have entered clinical trials 
(Capron et al., 2005).  
The most promising S.mansoni vaccine antigens discovered in 
the last 10 years are; Tetraspanins of which Sm23 (Wright et al., 
1991) expressed in the tegument of S.mansoni. It is most efficacious 
when deliverd as DNA vaccine (Da,Dara et al., 2003). Two new 
S.mansoni Tetraspanins expreesed in the tegument membrane of 
S.mansoni are (SmTSP-1 and SmTSP-2) (Smyth et al., 2003). 
SmTSP-2 in particular provided high levels of protection as a 
recombinant vaccine in the mouse model of Schistosomiasis, and both 
proteins were strongly recognized by IgG1 and IgG3 from PR 
individuals (Tran et al., 2006). 
1.2.10 The future:  
Despite the global efforts of many researches, schistosomiasis is 
still a major parasitic disease. Several problems remain to be resolved, 
such as the identification of new vaccine candidate molecules and how 
to deliver them effectively, and the precise mechanisms of immune 
regulation. More knowledge of schistosome biology is sought to 
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appreciate how the parasite interacts with, and evade the mammalian 
immune system (El-Sayed et al., 2004). Considering the high 
prevalence of parasite infections they are so well adapted to the host 
that the immune response is not able to destroy them (Araujo et al., 
2004). 
 Hopes have been raised by the recent characterization of the 
genome (El-Sayed et al., 2004) of S. mansoni. With this come the 
potential for the discovery of new drug targets that will aid the fight. 
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CHAPTER TWO 
MATERIALS AND METHOD 
   
2.1 Materials 
2.1.1 Study area: 
The study was conducted in Elkeryab village situated in the 
Eastern Nile Locality in Khartoum state. The criterion for selection 
Elkeryab village is the fact that it contains water polluted with 
different types of schistosomes. 
2.1.2 Study population: 
The study population was, mainly School children. 
i-  20 children who were not exposed to S. mansoni parasite were 
selected to serve as controls.  
ii-   40 children were selected to represent individuals who were 
frequently exposed to high intensities of infection, these 
children were divided into three groups according to age , 
below teen age: Group A (5-7) Years, Group B (8-11) Years 
and teen age: Group C (12-16) Years.  
2.1.3 Materials for ELISA: 
a) Soluble Worm Anigen (SWA): 
         Obtained from an in house prepared antigen from Tropical 
Medicine Research Institute 
b) Phosphate buffer saline: (PBS) (PH 7.4):               
In 800 ml of distilled water 8 g of NaCl, 0.2 g of KCl, 1.44 g of 
Na2HPO4 and 0.24g of KH2PO4 were dissolved, pH was adjusted to 
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7.4 with HCL, and the volume was made to 1 litre. The buffer was 
then stored at 4°C.  
c) Phosphate buffer saline/tween 0.05%: 
One liter of phosphate buffer saline/ tween20 was prepared by   
adding 0.5 ml of tween20 to 999.5 of PBS buffer. 
d) Bovine serum albumin (BSA): 
Three grams of bovine serum albumin (BSA) (Product No. A-
3425, Sigma) was dissolved in 99 ml of distilled water and stored at 
4°C for a maximum of four days. 
e) 0.05 M carbonate-bicarbonate buffer (pH 9.6):                                                                 
1.59 g of anhydrous sodium carbonate (Na2CO3), 2.93 g sodium 
bicarbonate was dissolved in 1 liter of distilled water and the pH was 
adjusted to 9.6 by adding HCL or NaOH.                                                                                                        
f)  Citrate buffer (pH 5):  
7.30 g of citric acid and 11.86 g of Na2HPO4 were dissolved in 
1 liter and the pH was adjusted to 5 by adding HCL or NaOH.                                                                  
g)  O-phenylene diamine dihydrochloride (OPD) powder:  
The substrate solution of OPD 0.04% powder was used to react 
to the specific enzyme conjugate, The substrate solution was prepared 
by dissolving 0.01 g of OPD in 25 ml of citrate buffer (5µlof H2 O2 
30% was added immediately before use) . 
h) Conjugates: 
Anti-human IgG (peroxidase conjugated IgG, Sigma A-8419), 
Anti- human IgG4 (Biotin-conjugated IgG4, Sigma B-3648), Anti-
human IgG3 (Biotin- conjugated IgG3, Sigma B-3523), Anti-human 
IgG2 (Biotin-conjugated IgG2, Sigma B-3398), Anti-human IgG1 
(Biotin- conjugated IgG1, Sigma B-6775) were used. 
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i) Polystyrene micro-titer plates:  
         Ninety six wells polystyrene micro-titer plates (Nunc- munoplate   
Maxisorp, 96 wells plate product no. 4-42404 Denmark) were used. 
j) Parafilm:  
        Parafilm "M" laboratory film (product no. 60631 Chicago). 
2.2Methods: 
2.2.1 Sample collections: 
The samples were collected in stool containers which were 
labeled and the samples were examined in Elkeryab health centre. 
Five ml of venous blood samples were collected from each patient and 
from controls.  
2.2.1.1 Stool examination:  
           Stool was examined by Kato technique (Teesdale and Amin, 
1976). Approximately 1-2 g of the sample was placed on a piece of 
paper and pressed through a 100 mesh sive (150µ m pore size). The 
sived stool was scraped from the sive surface with a slide and 
compacted into 1.0 mm disposable syring calibrated to hold 25 mg of 
the seived stool. The 25 mg were then pressed out into a slide and the 
process was repeated for three slides. Each slide was then covered 
with clean slide and pressure was applied with the finger until the 
faecal matter spread to cover an area of 20-25mm in diameter. The 
slides were examined immediately under the microscope and the eggs 
were counted on each slide. An average of the egg count on the three 
slides was taken. The results were then expressed as eggs per gram 
(e/g). 
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         2.2.1.2 Sera preparation: 
 Sera were separated by centrifuging the blood samples after 
letting them to clot. The sera were then divided into vials and stored at         
-20°C. 
2.2.2 ELISA method: 
An indirect ELISA assay was used to measure specific IgG and 
its subclasses IgG1, IgG2, IgG3, and IgG4 against Soluble Worm 
Antigen (SWA) in the sera of selected children. The method adopted 
was that of (Voller et al., 1979; Satti et al., 1996).   
Ninety six wells polystyrene, flat bottom micro-titer plates were 
chosen to run the assay. The antigen SWAwas dissolved in 0.05 M 
carbonate buffer pH (9.6) and each well in a plate was coated with 50 
µl. (concentrations shown in table 1). The plates were covered with 
parafilm, and were then incubated overnight at 4°C. Each plate was 
then washed three times with PBS (pH 7.4), containing 0.05% tween20 
i.e. (PBS-tween20). Then to each well 100 µl of 3 % bovine serum 
albumin (BSA) was added as a blocking agent, the plates were 
covered with  parafilm, and were incubated at 37°C for 1-2 hours, then 
the blocking buffer was discarded. Two wells were left without 
antigen as a blank and only coating buffer was added. In each plate 10 
wells were left as controls. 100 µl of each sample of serum (1: 500 
diluted in 3% bovine serum albumin) were added to wells, the plates 
were covered with parafilm, and were incubated at 37°C for one hour.  
The plates were then washed three times with PBS-tween20 .100 
µl of anti- human IgG peroxidase conjugate (1:5000 diluted with PBS-
tween20) were added to each well. The plates were covered with 
parafilm, and were further incubated for one hour at 37°C. The plates 
were then washed three times with PBS-tween20. For the estimation of 
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immunoglobulin subclasses another layer of avidin (concentration was 
the same as the conjugate) was added. The plates were covered with 
parafilm, and were incubated for one hour at 37°C. The plates were 
then washed three times with PBS-tween20.  And to each well 100 µl 
of peroxides substrate solution consisting of O- phenylene Diamine 
dihydrochloride (OPD) with 5 µl of hydrogen peroxide (H2 O2) were 
added immediately before use. The plates were covered with parafilm, 
and were incubated with substrate for 5-30 minutes at room 
temperature in the dark. The reaction was stopped by the addition of 
50 µl of 20 % of sulfuric acid (H2 SO4). The Optical Density (OD) was 
measured using ELISA reader at 490 nm.  
Results were then expressed as the mean of duplicate wells after 
subtraction of the blank, which are the readings of the two wells 
without sera. Optical densities greater than the mean value of the 
controls plus 2 standred deviations were considered to be positive 
infection (Mansour et al., 1991).        
 
Table 1: ELISA Reagent concentrations used for IgG and IgG 
subclasses against S.mansoni SWA 
IgG/ 
Subclasses 
Antigen 
dilution 
µ g/µ l 
Sera 
Dilution 
µ l/ml 
Conjugate           
dilution 
µ l/ml 
Avidin 
dilution 
µ l/ml 
IgG 5 1/500 1/5000 * 
IgG1 3 1/500 1/4000 1/4000 
IgG2 2 1/500 1/2000 1/2000 
IgG3 5 1/500 1/2000 1/2000 
IgG4 5 1/500 1/5000 1/5000 
     * IGg measurement does not require the presence of Avidin layer 
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2.2.3 Statistical Methods:  
Data was analyzed using the Statistical package for Social 
Science (SPSS) (Nei et al., 1975). The data was analyzed for three age 
groups, T- test was used to compare the immunoglobulins between the 
infected and non- infected children. 
ANOVA was used to compare IgG and its subclasses between 
the infected and the control in each age group and between the 
different age groups within either the infected or the non-infected 
children. 
 The Correlation Coefficient analysis (Gomes and Gomes, 
1984) was used to analyzed IgG and its subclasses against SWA 
within the infected and non- infected children. 
The egg counts of the infected individuals were normalised by 
obtaining the Geometric Mean Egg Count (GMEC) of those who were 
infected.     
GMEC= nv x1 x2 x3… xn 
 ANOVA was used to determine the differences in the intensity 
of infection. 
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CHAPTER THREE 
RESULTS 
 
3.1  Intensity of infection:  
The intensity of S. mansoni infection was measured by the 
Geometric Mean Egg Count (GMEC) shown in table 2 and illustrated 
in fig.2 Analysis of variance showed that there were high significant 
differences among the three age groups in the level of intensity of 
infection. The highest intensity of infection (57.8) was obtained for 
the age group C 12-16Years (P<0.0001). The intensity of infection 
(34.4) obtained for the age group B 8-11 Years was very significant 
(P<0.0001) compared to that for the age group A 5-7 Years which had 
the lowest intensity of infection (11.7). 
Table 2: Intensity of S. mansoni in infected school children 
          N= number of children investigated 
           A= age 5-7 Years        
          B = age 8-11Years 
          C = age 12-16 Years 
          epg = egg per gram of feces 
          GMEC = Geometric Mean Egg Count 
Age  groups/ 
years 
Egg Counts 
(epg) 
 Intensity of  Infection 
(GMEC) 
A 
N=10 
131 11.7 
B 
N=11 
397 34.4 
C 
N=19 
1110 57.8 
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   Fig 2: Intensity of S.mansoni in infected school children 
                      A= age 5-7 Years        
                      B = age 8-11Years 
                      C = age 12-16 Years 
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3.2 Total specific Immunoglobulin (IgGs) levels against SAW in 
different age groups: 
        There was a remarkable difference in the total immunnoglobulin 
levels against SWA in the different age groups of infected children 
that is not reflected in their counterpart control groups.   
         The results are presented in the table 3and illustrated in fig.3 
reveal a significant increase in antibody production with age. The 
average production with schistosoma infection in children aged 12-16 
years is almost 100% more than the level of production in those 
infected children aged 8-11 years, the same is true for latter  age group 
when compared to younger children between 5 and 7 years of age. 
This reflects a consistent increase of immunoglobulin production in 
older children (teen age). This increase is not paralleled in the control 
equivalent sub age groups (with mean levels ranging 0.09 + 0.01 to 
0.12 ± 0.05). IgG levels against SWA in all the infected age groups 
A,B and C were significantly difference when compared with their 
respective control groups (P<0.01, P<0.001 and P<0.0001) 
respectively.    
IgG responses against SWA increased significantly with increasing 
intensity of infection being higher (P<0.0001) in children with 
intensity of infection 57.8 than those with intensity of infection 34.4 
and 11.7. 
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Table 3: Mean IgG levels against S.mansoni SWA in infected 
and non-infected children of different age groups  
                          
                 
 
 
 
 
                       N= number of children investigated 
                       A= age 5-7 Years        
                       B = age 8-11Years 
                       C = age 12-16 Years      
   
 
 
 
 
 
 
 
 
 
 
Age groups/ 
Years 
IgG (OD)  
in infected 
Mean ± SD 
IgG(OD)            
in non- infected 
Mean ± SD 
A 
 
0.34 ± 0.1 
N = 10 
0.12 ±  0.05 
N = 5 
B 
 
0.60  ±  0.1 
N = 11 
0.12 ± 0.04 
N = 5 
C 
 
1.30  ±  0.3 
N = 19 
0.09 ± 0.01 
N = 10 
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      Fig. 3: GMEC and Mean IgG levels against S.mansoni SWA 
in infected and non- infected children of different age 
groups  
 
                 A= age 5-7 Years 
                 B = age 8-11Years 
                 C = age 12-16 Years 
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3.3 Immunoglobulin (IgG) subclasses against SWA in different 
age groups: 
      Immunoglobulin (IgG) subclasses were investigated to see which 
subclass predominate in schistosoma infections. There was a 
remarkable difference in the IgG subclass levels against SWA in all 
age groups of infected children that is not reflected in the counterpart 
control groups.   
     The results are presented in the respective tables and figures in the 
following sections, as indicated. 
3.3.1 IgG1: 
 The results of IgG1 levels against SWA in infeted and non-infected 
children are presented in table 4 and illustrated in fig. 4 IgG1 levels 
against SWA increased significantly with age being higher (P<0.001) 
in group C when compared to group B and group A, while there were 
no significant differences (P>0.05) between A and B age groups. 
However IgG1 levels against SWA in age group A and B were 
significantly higer than the control counter parts (P<0.001), IgG1 
levels in age grop C was significantly difference (P<0.0001) than their 
respective control.     
IgG1 responses against SWA increased significantly with increasing 
intensity of infection (P<0.001) in children with intensity of infection 
57.8 than those with intensity of infection 34.4 and 11.7. 
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Table 4: Mean IgG1 levels against S.mansoni SWA in infected and 
non – infected children of different age groups 
 
 
 
 
 
 
 
 
 
 
           
                    N = number of children investigated 
                    A = age 5-7 Years        
                    B = age 8-11Years 
                    C = age 12-16 Years        
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Age  groups/     
Years 
IgG1 (OD) 
in infected 
Mean ± SD 
IgG1 (OD)  
in non- infected 
Mean ± SD 
A 0.16 ± 0.003 
N=10 
0.11 ± 0.01 
N=5 
B 0.17 ± 0.01 
N=11 
0.08 ± 0.01 
N=5 
C 0.24 ± 0.01 
N=19 
0.12 ± 0.02 
N=10 
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     Fig. 4: GMEC and Mean IgG1 levels against S.mansoni SWA in 
infected and non- infected children of different age groups 
 
              A= age 5-7 Years 
              B = age 8-11Years 
              C = age 12-16 Years 
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3.3.2 IgG2: 
The results are presented in table 5 and illustrated in fig. 5 
 There was a highly significantly relationship between age groups and 
IgG2 responses to SWA. IgG2 levels against SWA increased 
significantly with age being higher (P<0.001) in group C when 
compared to group B and group A, while there were no significant 
differences (P>0.05) between A and B age groups. However IgG2 
levels against SWA in age group A and B were significantly higer 
than the control counter parts (P<0.001), IgG2 levels in age grop C 
was significantly difference (P<0.0001) than their respective control.     
IgG2 responses against SWA increased significantly with increasing 
intensity of infection, being higher (P<0.001) in those children with 
intensity of infection 57.8 than those with intensity of infection 34.4 
and 11.7. 
 
Table 5: Mean IgG2 levels against S.mansoni SWA in infected and 
non – infected children of different age groups 
Age groups/     
Years 
IgG2(OD) 
in infected 
Mean ± SD 
IgG2(OD) 
in non-infected 
Mean ± SD 
A 
  
0.14 ± 0.01 
N=10 
0.11 ± 0.01 
N=5 
B 0.15 ± 0.01 
N=11 
0.08 ± 0.02 
N=5 
C 0.21 ± 0.04 
N=19 
0.10 ± 0.01 
N=10 
          
                        N= number of children investigated 
                        A = age 5-7 Years        
                        B = age 8-11Years 
                        C = age 12-16 Years        
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      Fig. 5: GMEC and Mean IgG2 levels against S.mansoni SWA 
in infected and non- infected children of different age 
groups 
          
              A = age 5-7 Years 
              B = age 8-11Years 
              C = age 12-16 Years 
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3.3.3 IgG3:    
       The results are presented in table 6 and illustrated in fig. 6 
IgG3 responses to SWA were significantly related to age, with an 
overall decline in response to age. Thus, children in the age group A 
had significantly higer IgG3 levels againt SWA (P<0.001) than 
children in the age group C and group B (P<0.01). Children in group 
B had significantly higer responses (P<0.001) than children in group 
C. IgG3 responses to SWA in the infected groups A, B and C were 
significantly higer (P<0.0001, P<0.001and P<0.01) than their 
respective control groups.  
There was inverse relationship between IgG3 and intensity of 
infection. IgG3 respones against SWA were significantly decreased as 
the intensity of infection increased, being lowest (P<0.001) in group C 
when compared to A and B (P<0.01) age groups.  
Table 6: Mean IgG3 levels against S.mansoni SWA in infected and 
non – infected children of different age groups 
 
 
 
 
 
 
 
 
                     N= number of children investigated 
                     A = age 5-7 Years        
                     B = age 8-11Years  
                     C = age 12-16 Years                                      
Age groups/ 
Years 
IgG3(OD) 
in infected 
Mean ± SD 
IgG3(OD) 
in non-infected 
Mean ± SD 
A 
  
0.25 ± 0.01 
N=10 
0.12 ± 0.01 
N=5 
B 0.23 ± 0.01 
N=11 
0.10 ± 0.02 
N=5 
C 0.16 ± 0.04 
N=19 
0.12 ± 0.01 
N=10 
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       Fig. 6: GMEC and Mean IgG3 levels against S.mansoni SWA        
in infected and non-infected children of different age   
groups 
          
                  A = age 5-7 Years 
                  B = age 8-11Years 
                  C = age 12-16 Years 
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3.3.4 IgG4:    
 
     The results are presented in table 7 and illustrated in fig. 7 The 
IgG4 against SWA responses were related to age, IgG4 levels against 
SWA increased significantly with age being higher (P<0.001) in group 
C when compared to group B and group A, while there were no 
significant differences (P>0.05) between A and B age groups.  
However IgG4 levels against SWA in age group A and B were 
significantly higer than the control counter parts (P<0.01, P<0.001). 
IgG4 levels against SWA in age group C was significantly difference 
(P<0.0001) than their respective control.     
IgG4 responses against SWA increased significantly with increasing 
intensity of infection (P<0.001) in children with intensity of infection 
57.8 than those with intensity of infection 34.4 and 11.7.    
 
Table 7: Mean IgG4 levels against S.mansoni SWA in infected and 
non – infected children of different age groups 
 
Age groups/ 
Years 
IgG4(OD) 
in infected 
Mean ± SD 
IgG4 
in non- infected 
Mean ± SD 
A 0.13 ± 0.01 
N=10 
0.08 ± 0.01 
N=5 
B 0.14 ± 0.01 
N=11 
0.08 ± 0.01 
N=5 
C 0.17 ± 0.02 
N=19 
0.07 ± 0.03 
N=10 
             
                       N = number of children investigated 
                       A = age 5-7 Years        
                       B = age 8-11Years 
                       C = age 12-16 Years       
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Fig. 7: GMEC and Mean IgG4 levels against S.mansoni SWA in 
infected and non- infected children of different age groups 
          
            A = age 5-7 Years 
            B = age 8-11Years 
            C = age 12-16 Years 
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3.4 Total specific Immunogloulins IgG and IgG subclasses against 
SWA within the age groups: 
   The results of the IgG and IgG subclasses responses against 
SWA within the infected and non infected age groups were analyzed 
using Correlation Coefficient Statistical Analysis.  The distribution of 
IgG and its subclasses responses against SWA varied considerably 
within the age groups of infected children, where there were no 
differences of these antibodies within the age groups of non infected 
children. The correlations of immunoglobulin responses are presented 
in table 8 and illustrated cumulatively in fig. 8 and for the different 
groups separately in 8a, 8b and 8c. 
The correlations of immunoglobulin responses in infected children of 
group A are illustrated in fig. 8a.  
 Total IgG was no significantly positively correlated with IgG1, IgG2 
and IgG4 (0.08, 0.05 and 0.09 respectively), IgG was significantly 
positively correlated with IgG3 (0.24*). 
IgG1 was significantly positively correlated with IgG4 (0.75*). IgG2 
was significantly negatively and highly correlated with IgG3  ( -0.85*). 
The correlations of immunoglobulin responses in infected children of 
group B are illustrated in fig. 8b.  
Total IgG was significantly positively correlated with IgG1, IgG2  and 
IgG4 (0.31*, 0.29* and 0.26* respectively) and IgG was significantly   
positively non correlated with IgG3 (0.01). 
IgG1 was significantly positively correlated with IgG4 (0.62*). IgG2 
was no significantly negatively correlated with IgG3  (-0.12). 
The correlations of immunoglobulin responses in infected children of 
group C are illustrated in fig. 8c.  
 Total IgG was significantly positively and highly correlated with 
IgG1, IgG2 and IgG4 (0.72*, 0.79*and 0.66* respectively) and IgG was 
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significantly negatively correlated with IgG3 (-0.42*). IgG1 was 
significantly positively and highly correlated with IgG4 (0.67*). IgG2 
was significantly negatively correlated with IgG3 (-0.15*). IgG3 was            
significantly negatively correlated with IgG4 (-0. 4*). 
 
Table 8: Total IgG and IgG subclasses against S. mansoni SWA  
           in infected and non-infected children within the age groups 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Children 
 
  
Means ± SD 
Age 
group/ 
years 
No. IGg IGg1 IGg2 IGg3 IGg4 
Infected 
A 10 0.34±0.1 0.16±0.003 0.14±0.01 0.25±0.01  0.13±0.01 
B 11 0.6±0.1 0.17±0.01 0.15±0.01 0.23±0.01 0.14±0.01 
C 19 1.30±0.3 0.24±0.01 0.21±0.04 0.16±0.04 0.17±0.02 
Non-
infected 
A 5 0.12±0.05 0.11±0.02 0.11±0.01 0.12±0.01 0.08±0.01 
B 5 0.12±0.04 0.08±0.01 0.08±0.02 0.10±0.02 0.08±0.03 
C 10 0.09±0.01 0.12±0.02 0.10±0.01 0.12±0.01 0.07±0.03 
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Fig. 8: Total IgG and IgG subclasses against S. mansoni SWA in 
infected and non-infected children within the age groups 
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Fig. 8a: Total IgG and IgG subclasses against S. mansoni SWA in 
infected and non-infected children within the age group A 
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Fig. 8b: Total IgG and IgG subclasses against S. mansoni SWA in 
infected and non-infected children within the age group B 
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Fig. 8c: Total IgG and IgG subclasses against S. mansoni SWA in 
infected and non-infected children within the age group C 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
 
 
 
 
 
0
0.2
0.4
0.6
0.8
1
1.2
1.4
Age group A   Age group B    Age group C
O
D
 IgG
IgG1
IgG2
IgG3
IgG4
 
 
Fig. 9: Total IgG and IgG subclasses against S. mansoni SWA in 
infected children within the age groups 
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CHAPTER FOUR 
DISCUSSION 
 
Schistosomaisis is a serious communicable disease in 
developing countries and its chronicity places a heavy burden on such 
communities' health resulting social and economical setbacks that 
ultimately hinders development. Studies carried out to identify the 
influence of host and parasite factors that give rise to characteristic 
antibody isotype profiles in human populations living in areas of 
schistosomiasis endemicity, showed that intensity and duration of 
infection are age-dependent (Naus et al., 1999).  
         This study was carried out to investigate the total specific 
immunoglobulin IgG and its subclasses IgG1, IgG2, IgG3 and IgG4 
against S.mansoni Soluble Worm Antigen SWA as it was shown to be 
most effective in serodiagnosis because it contains many proteins 
which could detect the antibodies produced by the patients (Imai, 
1987; Cho, et al., 1989; Cha et al., 1994).   
The present study was conducted in the El Keryab Primary School 
which contains children who were selected to represent individuals 
frequently exposed to high intensities of infection in the El Keryab 
village which contains water infested with different types of 
schistosomes.  
In this research the study population was composed of infected and 
non-infected children alocated to three age groups; A (5-7), B (8-11) 
below teens and C (12-16) teenage.This arbitrary classification is 
justified by differences in behavioural patterns and water contact of 
these children. Infected children presented significantly higher levels 
of all the immunoglobulins than the control groups. 
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Human populations living in areas in which schistosomiasis is 
endemic develop antiparasite antibody isotype responses which have 
distinct roles in immunity to infection and re-infection (Butterworth   
et al., 1988; Khalife et al., 1989; Hagan et al., 1991; Dunne et al., 
1992a and b; Rihet et al., 1992; Demure et al., 1993). The surveys of 
human populations suffering schistosomiasis have shown that there 
are dynamic changes of the antibody response to schistosomes with 
the age of infected patients (Dunne et al., 1993).                               
         In the present study the teenage children had the highest 
intensity of infection compared to younger age groups which suggests 
that there is a conistant increase of intensity of infection with age 
which could be attributed to extended exposure with time. This 
finding is supported by Kabatereine et al. (1999) who observed the 
frequency of water contact and concluded that infection intensities rise 
in early childhood, peak around the age 11-16 years, and then rapidly 
decline. In schistosomiasis infection it is possible that the lower 
intensities of infection seen in adults may result from acquisition of 
immunity due to exposure to chronic antigen stimulation 
(Butterworth, 1990).  
In the present study it was found that the peak of infection intensity 
was found around the age 12-16 years, typicaly described in 
population living in areas of endemicity (Hagan, et al. 1991; Dunne et 
al., 1992a; Ndhlovu et al, 1996; Fulford et al., 1998).  
      Schistosomiasis-spesific antibody isotype responses, like 
observed levels of infection intensity, show similar dynamic patterns 
with age in schistosomiasis endemic areas (Butterworth et al., 1988; 
Hagan et al., 1991;Dunne et al., 1992a; Ndhlovu et al., 1996; Webster 
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et al., 1997a). Our observations that many of the antibody isotype 
responses against worm antigens increase with age agree with the 
observations of other authors (Hagi et al., 1990; Hagan et al., 1991; 
Dunne et al., 1992a; Hakangard et al., 1996; Ndhlovu et al., 1996; 
Van Dam et al., 1996; Webster et al., 1997a; Naus et al., 1999, 2003).    
The infected children in group C were found to have high IgG 
levels against SWA, which increase with age. This result is typical to 
that found by Hagan et al. (1991). In Schistosomiasis infections, it has 
been proposed that naturally acquired immunity to Schistosomiasis 
may be linked to key features of the immune system that change 
during normal human development and aging (Baird, 1998; Fulford    
et al., 1998).   
 Naus et al. (2003) found that children from an area highly 
endemic for S. mansoni had elevated levels of IgG were accounted for 
by IgG1, and IgG2.This was agreeing with the present study where IgG 
levels against SWA were found to be significantly positively 
correlated with IgG1 and IgG2. Levels of IgG1 and IgG2 against SWA 
were correlated with infection intensity (Dunne et al., 1992a; Viana et 
al., 1995; Satti et al., 1996; Van Dam et al., 1996). Similar findings 
have been reported for S.haematobium infection (Grogan et al., 1996; 
Ndhlovu et al., 1996; Naus et al., 1998) and for other helminth 
infection. 
The infected children in the group C were found to have highest 
IgG1 levels against SWA and highest intensity of infection and this is 
agreement with the finding that IgG1 levels increase as the intensity of 
infection increases (Naus et al., 1999).   
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There were no differences in the levels of IgG1and IgG2 
between group A and B and this is due to the fact that IgG1 and IgG2 
responses against SWA were strongly related to egg counts increasing, 
with an increase in egg counts. This is in agreement with Naus et al. 
(2003) when they concoluded that there was significant variation in 
the IgG1-SWA and IgG2-SWA responses with egg counts. The 
explanation of this observation is that, egg counts were correlated with 
worm burdens. Early studies have demonstrated that excretion of eggs 
is linearly associated with wrom burdens (Dunne et al., 1992a) 
The infected children in the group C were found to have highest 
IgG2 levels against SWA. This group of children has high blocking 
antibodies (IgG2) and low protective antibodies (IgG3), this was also 
found by Butterworth et al. (1992), Dunne et al. (1992a) and Satti et 
al. (1996). In this study it has been found that IgG2 levels against 
SWA were significantly negatively correlated with IgG3 indicatig that 
as children get older there is an increase of the blocking antibodies 
and a decrease of the protective antibodies. 
The infected children in the group A were found to have highest 
IgG3 levels against SWA. Some studies have found   no difference in 
IgG3 levels against SWA between established and late Schistosomiasis 
patients (Iskander et al., 1981; Shaheen et al., 1996) or between 
normally exposed individuals and more intensively exposed canal 
cleaners (Satti et al., 1996). When compared to non-infected children, 
IgG3 levels against SWA are elevated in infected individuals. This 
indicates that IgG3 levels against SWA are affected by duration of 
infection rather than intensity of infection or age (Iskander et al., 
1981). Similar result was found by Naus et al. (1999) who found that 
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IgG3 levels against SWA were related to duration of exposure and 
showed negative association with either infection intensity or age. 
The infected children in group C were found to have highest 
IgG4 levels against SWA. Previous studies showed that IgG4 levels 
against SWA were high in late than in established schistosomiasis 
infection, suggesting that IgG4 levels against SWA have been shown 
to be increaed with progress of the disease, it is an indication of 
prolonged infection (Iskander et al., 1981; Evengard et al., 1988). 
Dunne et al. (1993) found that the levels of IgG4 against SWA 
correlate more with the age-related rise and fall with intensity of 
infection seen in endemic populations. Naus et al. (1999) found that 
levels of IgG1 and IgG4 against SWA antigens were strongly 
associated with intensity of infection and found that IgG4 were 
elevated in those suffering high intensities of infection. The peak 
levels of IgG1 and IgG4 against SWA antigens with age coincided with 
their respective peaks of infection intensity with age. (Iskander et al. 
1981; Satti et al. 1996).This is in agreement with the present study 
where it is found that as the children become older the intensity of 
infection increase and the relation between IgG1 and IgG4 become 
significantly positively highly correlated. 
It is of great interest to examine which host or parasite factors 
influence these specific antibody responses in schistosomiasis 
infection. Some years ago, specific antibody response patterns with 
age have been reported in a study of an epidemic outbreak of S. 
mansoni in Senegal (Van Dam et al., 1996), suggesting that patterns 
of responses seen in population in areas of endemicity are not 
dependant on long exposure to infection (Hagi et al., 1990; Hagan et 
al., 1991; Dunne et al., 1992a; Ndhlovu et al., 1996; Webster et al., 
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1997a). It is not clear why different isotype responses might be related 
to age or to intensity of infection (Lal et al., 1991; Langley et al., 
1994).   
It has been observed that the influence of host age was the strongest 
related factor that affects the isotype response against worm antigens 
in schistosomiasis endemic area (Langley et al., 1994).   
In addition to the effect of age on the antibody isotype responses 
against worm antigens, there are some factors that affect the isotype 
response like the length of time spent in the endemic area (Eloi-Santos 
et al., 1989; King et al., 1998).The higher intensities of infection 
reported among children within the first and second decades of life 
reflect the impact of exposure extent on the pattern of S. mansoni 
infection in the study area. For instance, children will have more water 
contact than adults, as they involve in both recreational and domestic 
activites in streams that are their source of water (Mduluza et al., 
2001; Nmorsi et al., 2007). Other differences between populations 
include nutritional status and history of exposure to other pathogens 
(Ouma et al., 1998). 
 The factors that affect the variety in the distribution of IgG and 
its subclasses within the age groups might be that different IgG 
subclasses have been shown to be induced by antigens with different 
physiochemical properties (Lal et al., 1991; Langley et al., 1994), and 
as a consequence of the structural differences the subclases show 
differences in their biological functions. 
The most important biological activites of antibodies are related to 
their effector functions, aimed at inactivation or removal of infection 
agents and their products (Capron, 1992).  Antibodies of IgG class 
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exert tow major functions: activation of complement and opsonisation, 
these effector functions mediated via the fc region (Dunne et al., 
1993).   
In this study it was found that within the all infected age groups 
A, B and C total IgG levels against SWA were high and this is due to 
its important role in ADCC when it binds to the surface of target 
cells.The most common Fc receptor (CD? ?  or R? ? ? ) exists on the 
surface of NK cells (Hagan et al., 1991). 
The four IgG subclasses differ from each other with respect to their 
effetor functions. These differences are related to differences in 
structure, notably with respect to the interaction between the variable, 
antigen-binding Fab fragment and the constant Fc region and the 
length and flexibility of the hinge region. (Dunne et al., 1993).The 
four human IgG subclasses show differences in their interaction with 
Fc? Rs which are expressed primarily on macrophages, monocytes and 
dendritic cells (Hagan et al., 1991).   
Within the all infected age groups the levels of IgG1 against SWA 
were high compared to IgG2 and IgG4 subclass and this due to its 
important biological functions (Its binding to proteins and 
Polysaccharides, Activation the complement {IgG1 second highest, 
IgG2 third highest activated the complement} and its binding to FcR?  
receptors on monocytes, macrophages and neutrophils, while FcR?  
receptors has apoor affinity for IgG4 and it does not bind IgG2 (Dunne 
et al., 1993).  
IgG3 has the longest hinge region with high flexibility and this 
probably relates to its higer activity in trigging effetor functions, when 
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compare to the other subclases is the most effective complement 
activator (Butterworth et al., 1992). 
  In the age group A the IgG3 levels against SWA were high and 
decreased with age until reach the low levels in the age group C and 
this is in agreements with the finding by Caldas, etal. (2000), when 
they attributed  the high IgG3 levels to their role in killing of S. 
mansoni  through binding to monocytes, macrophages and eosinophils 
receptors in below teenage children  and their intensive contact with 
water and exposure to infection.  
In summary the recorded observation in this study agrees with 
previous ones that the intensity of infection and age are the primary 
factors that induce the antibody isotype responses against SWA 
between infected children in different age groups, while the biological 
funcions of isotypes affect the distribution of antibody isotype 
responses against SWA within the age groups. 
 
 
 
 
 
 
 
 
 
 
 
 
 
Please purchase PDFcamp Printer on http://www.verypdf.com/ to remove this watermark.
 
CONCLUSION AND RECOMMENDATION 
 
        Many infectious diseases show a marked age dependency in their 
prevalence, intensity and severity. In the case of human helminth 
infections such as schistosomes, exposure of the parasite is often age- 
dependent, resulting in characterstic age-related patterns of infection 
intensity (Naus et al., 1999). The results were presented in this 
investigation showed that intensity of infection increased significantly 
with age. 
     Total IgG and its subclasses levels against SWA in the infected 
groups vary significantly with age, while this was no reflected in the 
correspondent control groups. 
    Most epidemiological studies regarding schistosomiasis in Sudan 
have been carried out in the Gazira-Managil areas and in other central 
and northern areas of economic importance, while relatively few 
studies have been conducted in other parts of the country (Deganello 
et al., 2007). 
In spite of increase the risk of schistosomiasis in Sudan especially in 
the major irrigation systems there were few studies that cover this 
infectious diease, so our recommendations are: 
· More studies are needed regarding Schistosomiasis in the 
different parts of Sudan to reveal the current situation of this 
infectious disease. 
· Immunological investigations of other isotypes such as IgE and 
how it relates to IgG patterns over age are also recommended to 
facilitate vaccination and treatment scopes. 
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